Form 483 Archives - Express Pharma

USFDA inspects JB Pharma’s manufacturing facility at Panoli, Gujarat

US FDA issues Form-483 with eight observations to Lupin’s drug, API production facilities in Mandideep plant

US FDA asks Panacea Biotec to take corrective measures at Himachal unit

Aurobindo Pharma subsidiary’s plant gets one observation from US FDA

US FDA issues Form 483 to Cipla’s facility in MP

Aurobindo Pharma’s Andhra unit gets three US FDA observations

Sun Pharma gets Form 483 from US FDA for regulatory violations at Halol plant

US FDA issues Form 483 to Lupin’s Goa plant

Alkem’s St Louis facility gets two observations from US FDA

US FDA makes five observations after Alembic Pharma facility inspection